Drug industry to fight New Zealand's move to ban direct to consumer advertising
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7447.1036-d (Published 29 April 2004) Cite this as: BMJ 2004;328:1036- Bob Burton
- Canberra
Moves by New Zealand's health minister, Annette King, to end advertising directly to consumers later this year by “harmonising” with Australian government standards has drawn opposition from the drug industry.
In December 2003 New Zealand and Australia signed a treaty to establish a single bi-national agency to regulate medicines, medical devices, and complementary health products on 1 July 2005 (2004;328:68). The text of the treaty was tabled in both parliaments in late March and is subject to review by parliamentary committees. Supporting documentation identified direct to consumer advertising as one of the differences where efficiencies could be made. …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.